Taken together, these findings indicate that correction of LH1 expression in Plod1-/ -mice by AAV-based gene therapy substantially alleviated Ang II-induced dissecting AAA formation and preserved aortic structure and function. The gene discussed is AGT; the disease is triple-A syndrome.